HK1250653A1 - Il-12作為造血免疫療法(hit)的用途 - Google Patents

Il-12作為造血免疫療法(hit)的用途

Info

Publication number
HK1250653A1
HK1250653A1 HK18110202.3A HK18110202A HK1250653A1 HK 1250653 A1 HK1250653 A1 HK 1250653A1 HK 18110202 A HK18110202 A HK 18110202A HK 1250653 A1 HK1250653 A1 HK 1250653A1
Authority
HK
Hong Kong
Prior art keywords
immunotherapy
hematopoietic
hit
hematopoietic immunotherapy
Prior art date
Application number
HK18110202.3A
Other languages
English (en)
Inventor
L‧A‧巴西萊
Original Assignee
創新療法醫藥有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 創新療法醫藥有限公司 filed Critical 創新療法醫藥有限公司
Publication of HK1250653A1 publication Critical patent/HK1250653A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/208—IL-12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pathology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK18110202.3A 2014-10-31 2018-08-08 Il-12作為造血免疫療法(hit)的用途 HK1250653A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462073220P 2014-10-31 2014-10-31
PCT/US2015/058363 WO2016070075A1 (en) 2014-10-31 2015-10-30 Uses of il-12 as an hematopoietic immunotherapy (hit)

Publications (1)

Publication Number Publication Date
HK1250653A1 true HK1250653A1 (zh) 2019-01-11

Family

ID=55851469

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18110202.3A HK1250653A1 (zh) 2014-10-31 2018-08-08 Il-12作為造血免疫療法(hit)的用途

Country Status (11)

Country Link
US (1) US20160120949A1 (zh)
EP (1) EP3212215A4 (zh)
JP (1) JP2017533279A (zh)
KR (1) KR20170088861A (zh)
CN (1) CN107708724A (zh)
AU (2) AU2015338998A1 (zh)
CA (1) CA2966218A1 (zh)
HK (1) HK1250653A1 (zh)
IL (1) IL251956A0 (zh)
SG (2) SG11201703516XA (zh)
WO (1) WO2016070075A1 (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10293058B2 (en) 2015-04-22 2019-05-21 Curevac Ag RNA containing composition for treatment of tumor diseases
KR101779370B1 (ko) 2016-06-29 2017-09-19 한국수력원자력 주식회사 방사선 조사 된 흉선 림프종 세포에서 발굴 된 세포고사 조절 유전자 및 그 검출방법
KR20190039145A (ko) * 2016-07-18 2019-04-10 뉴메디슨즈, 인코포레이티드 대체 면역요법으로서의 il-12의 용도
WO2019126384A1 (en) * 2017-12-19 2019-06-27 Neumedicines Inc. Effective il-12 dosing regimens
CN113557242A (zh) * 2019-02-01 2021-10-26 得克萨斯大学体系董事会 用于治疗癌症的修饰的il-12 t细胞疗法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7939058B2 (en) * 2003-07-03 2011-05-10 University Of Southern California Uses of IL-12 in hematopoiesis
US20090047241A1 (en) * 2007-06-20 2009-02-19 University Of Southern California Il-12 facilitates both the recovery of endogenous hematopoiesis and the engraftment of stem cells after ionizing radiation
US9878012B2 (en) * 2010-05-18 2018-01-30 Neumedicines, Inc. IL-12 formulations for enhancing hematopoiesis
EP2804620A4 (en) * 2012-01-18 2016-04-13 Neumedicines Inc IL-12 FOR RADIATION PROTECTION AND RADIATION-RELATED TOXICITY WEAKENING
WO2014160318A1 (en) * 2013-03-13 2014-10-02 Neumedicines, Inc. Endogenous vaccine for cancer and infectious diseases

Also Published As

Publication number Publication date
AU2015338998A1 (en) 2017-05-18
WO2016070075A1 (en) 2016-05-06
SG10202103474YA (en) 2021-05-28
JP2017533279A (ja) 2017-11-09
AU2021212068A1 (en) 2021-08-26
CN107708724A (zh) 2018-02-16
US20160120949A1 (en) 2016-05-05
EP3212215A1 (en) 2017-09-06
IL251956A0 (en) 2017-06-29
CA2966218A1 (en) 2016-05-06
SG11201703516XA (en) 2017-05-30
EP3212215A4 (en) 2018-07-11
KR20170088861A (ko) 2017-08-02

Similar Documents

Publication Publication Date Title
HK1231509A1 (zh) 培養基組合物
IL246681A0 (en) Materials and preparations containing them for use in immunotherapy
IL253341A0 (en) Methods and preparations for combined immunotherapy
SG11201609635XA (en) Novel high clarity low haze compositions
SG11201610807SA (en) Turbo chiller
EP3125895A4 (en) Substituted spirocydic inhibitors of autotaxin
GB201413564D0 (en) Time of flight determination
EP3218443A4 (en) Refrigerant compositions and methods of use
PT3107573T (pt) Imunoterapia com il-12 visada ao cancro
HK1250653A1 (zh) Il-12作為造血免疫療法(hit)的用途
EP3129753A4 (en) Compositions and methods for delivery of carbon dioxide
EP3190886A4 (en) Compositions and methods of use thereof
IL248194A0 (en) Acrylic resin preparations, materials containing them and methods of their production
EP3127287A4 (en) Signaling and operation of an mmtp de-capsulation buffer
SG11201701402QA (en) Anti-tumor compositions and methods
EP3376862A4 (en) CRYOPRESERVATION COMPOSITIONS AND METHODS OF USE
SG10202007893TA (en) Methods of immunotherapy
PL3223846T3 (pl) Kompozycje adiuwantowe i powiązane sposoby
HK1243404A1 (zh) 色酰胺組合物和使用方法
PL3113774T3 (pl) Kompozycje grapiprantu i sposoby ich zastosowania
EP3228322B8 (en) Adjuvant composition
IL250269A0 (en) Repeated fed-batch culture methods
GB2532702B (en) The determination of the characteristics of magnets
GB201404700D0 (en) Novel Composition
GB201412359D0 (en) Composition of objects